Evidence map›Paper›PMID 35249118›Full record

Trial reportEuropean journal of nutrition2022

The effect of Bacillus coagulans Unique IS-2 supplementation on plasma amino acid levels and muscle strength in resistance trained males consuming whey protein: a double-blind, placebo-controlled study.

Mohamad Tarik, Lakshmy Ramakrishnan, Nidhi Bhatia, Ravindra Goswami, Devasenathipathy Kandasamy, Atanu Roy, Dinu S Chandran, Archna Singh, Ashish Datt Upadhyay, Mani Kalaivani and 3 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Nutrients · 2026
    Trial
  5. Efficacy ofNutrients · 2024
    Trial
  6. The probioticGut microbes
    Trial
  7. Article
  8. Review
  9. Effects ofLife (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Progress of research and application ofFrontiers in cellular and infection microbiology · 2024
    Review
  17. Preclinical Safety Assessment ofMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohamad TarikDepartment of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India.
Lakshmy RamakrishnanDepartment of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India. lakshmy_ram@yahoo.com.
Nidhi BhatiaDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Ravindra GoswamiDepartment of Endocrinology & Metabolism, All India Institute of Medical Sciences, New Delhi, 110029, India.
Devasenathipathy KandasamyDepartment of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, 110029, India.
Atanu RoyDepartment of Physiology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Dinu S ChandranDepartment of Physiology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Archna SinghDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India.
Ashish Datt UpadhyayDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Mani KalaivaniDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Jayanthi NeelamrajuCentre for Research & Development, Unique Biotech Ltd., Alexandria Knowledge Park, Hyderabad, 500038, Telangana, India.
Ratna Sudha MadempudiCentre for Research & Development, Unique Biotech Ltd., Alexandria Knowledge Park, Hyderabad, 500038, Telangana, India.
Reena RajanDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, 110029, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the present study was to assess the effect of Bacillus coagulans Unique IS-2 supplementation on absorption and utilization of protein in resistance-trained males.

methodsIn this double blind, placebo-control trial, resistance-trained males (21.08 ± 2.84 years) were randomized to consume, either 20 g of whey protein powder {80% whey protein concentrate (WPC80), amounting to 15.4 g protein} with 2 billion CFU Bacillus coagulans Unique IS-2 (supplemental group) or 20 g of whey protein powder and lactose instead of Bacillus coagulans (placebo group) once daily for 60 days with a controlled resistance exercise protocol. The whey protein concentrate (WPC-80) given to both groups had a lactose content of 6.8%. Plasma-free amino acids (PFAAs) were determined at baseline, at 30 and 60 days of supplementation. Muscle strength, hypertrophy, VO2 max, and body composition, and other biochemical parameters were assessed at baseline and end line.

resultsA positive effect of probiotic Bacillus coagulans Unique IS-2 supplementation was observed on protein absorption as evidenced by an increase in total PFAA by + 16.1% (p = 0.004). Branched chain amino acids (BCAA) comprising isoleucine (p = 0.016), leucine (p = 0.001), and valine (p = 0.002) were increased by + 33.1% in ITT analysis as compared to placebo after 60 days. At 30 days an increase in isoleucine by + 35% (p = 0.113), leucine by + 43% (p = 0.032), and valine by + 32% (p = 0.017) was observed in ITT analysis. Probiotic effect was shown on exercise performance as evidenced by an increase in one RM of leg press and vertical jump power by + 16.61% (p = 0.024) and + 7.86% (p = 0.007), respectively.

conclusionSignificantly increased absorption of BCAA with supplementation of B. coagulans Unique IS-2 along with whey protein and improvement in leg press and vertical jump power was noted indicating the positive effect of the probiotic on muscle power in the lower body. TRIAL REGISTRATION NUMBER: CTRI/2017/03/008117; Date:16.03.2017.

Indexed as

Bacillus coagulansResistance TrainingDietary SupplementsDouble-Blind MethodHumansIsoleucineLactoseLeucineMaleMuscle, SkeletalMuscle StrengthPowdersProteinsValineWhey ProteinsIsoleucineLactoseLeucinePowdersProteinsValineWhey ProteinsAmino acidsAthletes performanceExerciseProbioticProtein absorption

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.